Article
Unraveling the therapeutic potential of the Hedgehog pathway in cancer.
Nature medicine - 1 Nov 2013
Amakye Dereck, Jagani Zainab, Dorsch Marion
Abstract excerpt
Major progress has been made in recent years in the development of Hedgehog (Hh) pathway inhibitors for the treatment of patients with cancer. Promising clinical trial results have been obtained in cancers that harbor activating mutations of the Hh pathway, such as basal cell carcinoma and medulloblastoma. However, for many cancers, in which Hh ligand overexpression is thought to drive tumor growth, results have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
